Wissenschaftliche Arbeiten

Prof. Dr. Vahit Özmen

883 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. 35.Ozmen V, Dolay K, Müslümanoğlu M, İğci A: Laparoscopic nissen fundoplication for the treatment of gastroesophageal reflux disease. Eurosurgery 2000, İstanbul, Turkey.

    Quelle: Profilseite auf florence.com.tr

  2. 36.Müslümanoğlu M, Karslıoğlu C, Özmen V, Yanar H, Ayalp K, Bozfakioğlu Y, Dağoğlu T, Unal M: Is the sentinel lymph node biopsy a reliable method in accurately predicting axillae in patients with breast cancer. Eurosurgery 2000, 20- 24 June 2000, İstanbul.

    Quelle: Profilseite auf florence.com.tr

  3. 37.Özmen V, Müslümanoğlu M, Dolay A. K., Karslıoğlu C, Yanar H, Beşışık F:Laparoscopic Nissen’ s Fundoplication for the treatment of gastroesophageal reflux disease.Eurosurgery 2000, 20-24 Haziran 2000, İstanbul.

    Quelle: Profilseite auf florence.com.tr

  4. 38.Cabioğlu N, Dağoğlu T, Tuzlalı S, İğci A, Doğan O, Müslümanoğlu M, Özmen V, Bozfakioğlu Y, Bilir A, Aydıner A, Keçer M, Parlak M : Predictive biological markers in evaluation of chemotherapy response in locally advanved breast cancer patients. 7th International Conference February 21-24, 2001 St Gallen / Switzerland. The Breast, Adjuvant Therapy of Primary Breast Cancer Vol.10, Suppl.1, February 2001, Abstract book; S22, P28.

    Quelle: Profilseite auf florence.com.tr

  5. 39.Asoğlu O, Özmen V, Müslümanoğlu M, İğci A, Parlak M, Bozfakioğlu Y, Keçer M, Dilege E : Sentinel lymph node biopsy in patients with invasive breast cancer: Is multifocality a contraindication to the sentinel lymph node biopsy? 1st Congress of the World Society for Breast Health (WSBH). September 22-25, 2001.

    Quelle: Profilseite auf florence.com.tr

  6. 40.Cabioglu N., A. Bilir, G. Yanikkaya-Demirel, A. Aydiner, A. Igci, Ozmen V “Synergistic antitumoral activity of paclitaxel combined with tamoxifen or medroxyprogesterone asetate against FM3A breast carcinoma cells through apoptotic pathway,” Abstract Book, 11th International Congress on Anti-Cancer Treatment, #221, Paris (France), 2001.

    Quelle: Profilseite auf florence.com.tr

  7. 41.Cabioglu N., A. Igci, E. Aktas, E.O. Yildirim, S. Bilgic, M. Muslumanoglu, Y. Bozfakioglu, M. Kecer, Ozmen V and G. Deniz, “An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer,” Proceedings of the American Society of Breast Surgeons, 3rd Annual Meeting of The American Society of Breast Surgeons, Vol.3, Boston (USA), 2002.

    Quelle: Profilseite auf florence.com.tr

  8. 42.Karanlık H, Ünal ES, Asoglu O, Özmen V, Kecer M, Bozfakioglu Y, Parlak M, Igci A, Müslümanoglu M: Granulomatous mastitis. 2nd Congress of The World Society for Breast Health, Budapest, Hungary, 24-28, June 2003.

    Quelle: Profilseite auf florence.com.tr

  9. 43. Karanlık H, Ünal ES, Asoglu O, Özmen V, Kecer M, Bozfakioglu Y, Parlak M, Igci A, Müslümanoglu M: The role of sentinel lymph node biopsy in breast cancer patients with excisional biopsy. 2nd Congress of The World Society for Breast Health, Budapest, Hungary, 24-28, June 2003.

    Quelle: Profilseite auf florence.com.tr

  10. 44. Ünal ES, Karanlık H, , Asoglu O, Özmen V, Kecer M, Bozfakioglu Y, Parlak M, Igci A, Müslümanoglu M: Results of breast conserving surgery. 2nd Congress of The World Society for Breast Health, Budapest, Hungary, 24-28, June 2003.

    Quelle: Profilseite auf florence.com.tr

  11. 45.Özmen V, Oran Şen E, Görgün E et al. : Histological and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett’s esophagus. 14th International Congress and Endo Expo 2005 September 14-17, 2005, San Diego, California, USA

    Quelle: Profilseite auf florence.com.tr

  12. 46.Özmen V. Barrett’s esophagus and laparoscopic Nissen fundoplication. European Surgical Society Meeting. November 21-25, 2005, Vienna, Austria.

    Quelle: Profilseite auf florence.com.tr

  13. 47.Özmen V. Breast cancer in Turkey. Ludwig Maximillian University, 13-15, June 2005, Munich, Germany.

    Quelle: Profilseite auf florence.com.tr

  14. 48.Özmen V. Thoracoscopic and laparoscopic esophagectomy for early esophageal cancer. October 1-4, 2006, Sophia, Bulgaria.

    Quelle: Profilseite auf florence.com.tr

  15. 49.Özmen V. Breast cancer in Turkey. Ludwig Maximillian University, 13-15, October 2006, Munich, Germany.

    Quelle: Profilseite auf florence.com.tr

  16. 50.Özmen V. Sentinel lymph node biopsy in early breast cancer. Ludwig Maximillian University, 13-15, October 2006, Munich, Germany.

    Quelle: Profilseite auf florence.com.tr

  17. 51.Ozmen V. Sentinel lymph node biopsy in early breast cancer: Controversies. 4th World Congress of the World Society for Breast Health, October 16-22, 2007, Tianjin, China.

    Quelle: Profilseite auf florence.com.tr

  18. 52.Ozmen V, Cabioglu N, Gulluoglu B, Özcinar B. Breast cancer risk factors among Turkish women. The Breast Health Global Initiative Consensus Conference, 1-4 October 2007, Budapest, Hungary.

    Quelle: Profilseite auf florence.com.tr

  19. 53.Ozmen V, Cabioglu N, Gulluoglu B, Ozcınar B. A pilot mammographic screening in Bahcesehir, Istanbul, Turkey. The Breast Health Global Initiative Consensus Conference, 1-4 October 2007, Budapest, Hungary.

    Quelle: Profilseite auf florence.com.tr

  20. 54.Ozmen V, Cabioglu N, Ozcınar B, Ozgen C, Tihan D, Mudun A, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Dagoglu T. Utility of internal mammary lymph node biopsy in breast cancer. 30th Annual San Antonio Breast Cancer Symposium. December 13-16, 2007, San Antonio, Tx.

    Quelle: Profilseite auf florence.com.tr

  21. 55. Cabioglu N, Igci A, Ozmen V, Muslumanoglu M, Dagoglu T, Sahin AA, Yidirim EO, Aktas E, Bilgic S, Price JE, Deniz G, Kecer M. CXCR coexpression with EGFR/HER-2 positivity in breast cancer is a poor prognostic factor in patients with isolated tumor cells in bone marrow. 30th Annual San Antonio Breast Cancer Symposium. December 13-16, 2007, San Antonio, Tx, USA.

    Quelle: Profilseite auf florence.com.tr

  22. 56.Cabioglu N, Ozmen V, H. Karanlık, M. Müslümanoğlu, A. İğci, T. Özmen, B. Özçınar, A. Mudun, S. Tuzlalı, T. Dağoğlu, M. Keçer ve M. Parlak, “Factors predicting sentinel and non-sentinel lymph node metastases in patients with breast cancer.” Abstract Book, EBCC-6, Eur J Cancer Suppl, Vol 6, No:7, p149, 2008.

    Quelle: Profilseite auf florence.com.tr

  23. 57.Ozmen V, Muslumanoglu M, Igci A, Canbay E, Ozcinar B, et al. Is the Sentinel Lymph Node Biopsy Accurate for Patients with Initially Clinically Axilla-Positive Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy? 31th Annual San Antonio Breast Cancer Symposium. December 10-14, 2008, San Antonio, Tx, USA.

    Quelle: Profilseite auf florence.com.tr

  24. 55.Ozcinar B, Güler SA, Ozmen V,. Gulluoglu BM, Kocaman N, Ozkan M, Oran ES, Saricam G, Muslumanoglu ME, Igci I, Kecer M, Dagoglu T, Parlak M. Morbidities after local/regional treatment of breast cancer and patients ‘quality of life.In thıs supplement primary therapy of early breast cancer 11 th International conference 2009.11-14 March 2009.St. Gallen Swıtzerland.

    Quelle: Profilseite auf florence.com.tr

  25. 56.Ozmen V, S Ozkan Gürdal, M Muslumanoglu, A Igci, S Tuzlali, B Ozcinar, E Canbay, M Keçer, T Dagoglu.Predictive Factor for residual tumor after lumpectomy for close margins.2009 ASCO Annual meeling.(May 20 Supplement).2009

    Quelle: Profilseite auf florence.com.tr

  26. 57.Ozmen V, Ozcinar B, S.A. Guler, B.M. Gulluoglu, N Kocaman, M Ozkan, M.E. Muslumanoglu, A Igci, M Kecer, T Dagoglu.Complications of local / regional treatment of breast cancer and quality of life. 2009 ASCO Annual meeling.(May 20 Supplement).2009

    Quelle: Profilseite auf florence.com.tr

  27. 58.A.S.Gur, B Unal, U Ozbek, V Ozmen, F Aydoğan, S Gokgoz, B Gulluoglu,E Aksaz, S Ozbas, S Baskan,A Koyuncu,A Soran.Validation of Breast Cancer Nomograms for Predicting the Non Sentinel Lymph Node Metastases after a Positive Sentinel Lymph Node Biopsy in a Multicenter study: The Turkish Federation of Breast Disease Associations Protocol MF08-01.16 Jun 2009.

    Quelle: Profilseite auf florence.com.tr

  28. 59. S Ozbas, V Ozmen, A Igcı,M Muslumanoglu, B Ozcinar, M Balkan, F Aydogan, T Canda, O Harmancıoglu, E Aksaz, B Gulluoglu, C Ozaslan, Z Canturk, M Kayahan,H Mersin,Z Utkan, S Kocak, N Ulufi, U Ozbek, A Dirican, O Andacoglu, A Soran. Predicting the likelihood of non-sentinel lymph node metastases in triple negative breast cancer patients with a positive sentinel lymph node; Turkish Federation of Breast Disease Associations Protocol MF09-01. 16 Jun 2009.

    Quelle: Profilseite auf florence.com.tr

  29. 60.D Balkose, A Mudun, B Ozcinar, V Ozmen, M Muslumanoglu, T Dagoglu, H Dongel, E Yavuz, S Cantez .Is sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy reliable?Nuclear Medicine & Molecular Imaging 2009. Annual Congress of the EANM 2009. Barcelona Spain.

    Quelle: Profilseite auf florence.com.tr

  30. 61. Cabioglu N, Ozmen V, Ozaydin A.N Gulluoglu B.M., Unalan P.C, Gorpe S.,Oner B.R., Aribal E., Thomas DB9, Anderson BO, Survey on a pilot mammographic screening programme in Istanbul, Turkey,European Breast Cancer Conference 7, 24- 27 March 2010 Barcelona Spain.

    Quelle: Profilseite auf florence.com.tr

  31. 62. Ozden B., Ozmen V., Arıncı A., A successfully reconstructed case of primary leiomyosarcoma of the breast , Modern Concepts: Breast Aesthetics and Reconstruction Conference 8- 10 July 2010, Solihull, UK

    Quelle: Profilseite auf florence.com.tr

  32. 63.Kayhan A, Karanlik H, Sibel Ozkan Gurdal SO, Cabioglu N, Ozaydin N, Ozturk E, Unal ES, Aribal E, Bahadir Gulluoglu B, Ozmen V. PRELIMINARY DATA OF A TURKISH POPULATION-BASED ORGANIZED BREAST CANCER SCREENING PROGRAM FROM BAHCESEHIR, ISTANBUL, TURKEY . XVIth International Congress of the S.I.S. 2010 Valencia. November 8-10, 2010.

    Quelle: Profilseite auf florence.com.tr

  33. 64.Gurdal SO, Karanlik H, Cabioglu N, Muslumanoglu M, Igci A, Ozmen V. Positive margins in breast conserving surgery: Is re-excision always necessary? XVIth International Congress of the S.I.S. 2010 Valencia. November 8-10, 2010.

    Quelle: Profilseite auf florence.com.tr

  34. 65.Kayahan M, Kadioglu H, Muslumanoglu M, Igci A, Ozmen V, Idiz O, Eralp Y, Tuzlali S. Trastuzumab use and survival in HER2 (+) nonmetastatic breast cancer among Turkish women. J Clin Oncol 29, 2011 (suppl 27; abstr 56). ASCO Breast Cancer Symposium 2011, USA.

    Quelle: Profilseite auf florence.com.tr

  35. 66.S. Keskin, Y. Eralp, E. Akisik, E. Akisik, A. Igci, M. Muslumanoglu, S. Yilmaz, M. Tunaci, H. Camlica, S. Tuzlali, P. Saip, N. Dalay, V. Ozmen, E. Topuz. The predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. J Clin Oncol 29: 2011 (suppl; abstr 10539) 65. 2011 ASCO Annual Meeting 2011, USA.

    Quelle: Profilseite auf florence.com.tr

  36. 67.Jacek Jassem, Florin Bacanu, Janis Eglitis, Jozef Mardiak, Tadeusz Pienkowski, Zsuzsanna Kahan, Vahit Ozmen, Monika Drobniene, Damir Vrbanec, Tatyana Semiglazova, Ljiljana Stamatovic, Constanta Timcheva, Suzana Vasovic, Piotr ZaborekPatient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey. 2012 ASCO Annual Meeting J Clin Oncol 30, 2012 (suppl; abstr 9046).

    Quelle: Profilseite auf florence.com.tr

  37. 68.Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Kahan Z, Lakshmaiah K, Mardiak J, Pienkowski T, Semiglazova T, Stamatovic L, Timcheva C, Vasovics S, Vrbanec D, Zaborek P. Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients – an International survey. San Antonio Breast Cancer Symposium 2012, December 4-8, 2012, San Antonio,Tx,USA.

    Quelle: Profilseite auf florence.com.tr

  38. 69.Cabioglu N, Ozkan-Gurdal S, Kayhan A, Ozaydın N, Aribal E, Ozmen V. Molecular profiles of screen-detected breast cancers from a Turkish breast cancer screening program. 2013 ASCO Annual Meeting, Chicago, USA J Clin Oncol 31, 2013 (suppl; abstr e12545).

    Quelle: Profilseite auf florence.com.tr

  39. 70.Ozmen V, Boylu S, Ok E, Canturk Z, Celik V, Kapkac M, Girgin S, Tireli M, Ihtiyar E, Demircan O, Baskan MS, Koyuncu A, Tasdelen I, Dumanli E, Ozdener F; Istanbul University, Istanbul, Turkey; Adnan Menderes University, Aydin, Turkey; Erciyes University, Kayseri, Turkey; Kocaeli University, Kocaeli, Turkey; Ege University, Izmir, Turkey; Dicle University, Diyarbakir, Turkey; Celal Bayar University, Manisa, Turkey; Osmangazi University, Eskisehir, Turkey; Acibadem University Adana Hospital, Adana, Turkey; Ankara University, Ankara, Turkey; Cumhuriyet University, Sivas, Turkey; Uludag University, Bursa, Turkey; Roche Pharmaceuticals, Istanbul, Turkey. Factors affecting time to seeking medical advice and start of treatment in breast cancer (BC) patients in Turkey. 2013 ASCO Annual Meeting, Chicago, USA. J Clin Oncol 31, 2013 (suppl; abstr e17529).

    Quelle: Profilseite auf florence.com.tr

  40. 71.Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk Z, Utkan Z, Ozaslan C, Evrensel T, Uras C, Aksaz E, Soyder A, Ugurlu U, Col C, Cabioglu N, Bozkurt B, Dagoglu T, Uzunkoy A, Dulger M, Koksal N, Cengiz O, Gulluoglu B, Unal B, Atalay C, Yildirim E, Erdem E, Salimoglu S, Sezer A, Koyuncu A, Gurleyik G, Alagol H, Ulufi N, Berberoglu U, Kennard E, Kelsey S, Lembersky B. Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study (protocol MF07-01) Turkish Federation of Societies for Breast Diseases, Istanbul, Turkey. December 10-14, 2013, San Antonio Breast Cancer Symposium 2013, San Antonio, Tx, USA.

    Quelle: Profilseite auf florence.com.tr

  41. 72.Ozmen V, Ozkan-Gurdal S, Kayhan A, Ozaydin N, Cabioglu N, Ozcinar B, Aribal E. Istanbul University, Faculty of Medicine, Istanbul, Turkey; Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey; Marmara University, Istanbul, Turkey; Faculty of Medicine, Acibadem University, Istanbul, Turkey; Faculty of Medicine, Marmara University, Istanbul, Turkey. Successful results of a population-based organized mammography screening program in a developing country: The Turkish experience. December 10-14, 2013, San Antonio Breast Cancer Symposium 2013, San Antonio, Tx, USA.

    Quelle: Profilseite auf florence.com.tr

  42. 73.Cabioglu N, Ozkan-Gurdal S, Kayhan A, Ozaydin N, Ozcinar B, Aribal E, Ozmen V. Faculty of Medicine, Acibadem University, Istanbul, Turkey; Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey; Marmara University, Istanbul, Turkey; Faculty of Medicine, Marmara University, Istanbul, Turkey; Faculty of Medicine, Istanbul University, Istanbul, Turkey. Molecular profiles of screen detected breast cancers: Final results of Turkish Bahcesehir breast cancer screening project. December 10-14, 2013, San Antonio Breast Cancer Symposium 2013, San Antonio, Tx, USA.

    Quelle: Profilseite auf florence.com.tr

  43. 74.Neslihan Cabioglu, Vusal Aliyev, Enver Özkurt, Sibel Özkan Gurdal, Beyza Ozcinar, Mehmet Kurt, Mustafa Tükenmez, Abdullah İgci, Mahmut Muslumanoglu, Vahit Ozmen, Fatih Levent Balci, Omer Bender. Feasibility of mammary ductoscopy in management of pathologic nipple discharge. 16th Annual Meeting of American Society of Breast Surgeons, April 29-May 3, 2015, Orlando, USA.

    Quelle: Profilseite auf florence.com.tr

  44. 75.Karakus S, Tükenmez M, Üçüncü M, Yüksel S, Karanlik H, Ekrem Y, Müslümanoğlu M, Iğci, A, Ozmen V, Dinçağ A, Cabioğlu N. Pure Mucinous Carcinoma With a Favorable Tumor Biology and Prognosis. 16th Annual Meeting of American Society of Breast Surgeons, April 29-May 3, 2015, Orlando, USA.

    Quelle: Profilseite auf florence.com.tr

  45. 76. Ozkurt E, Tukenmez Mustafa, Ozden Burcu C, Oner Gizem, Guven Erdem, Muslumanoglu M, Iğci Abdullah, Ozmen, Vahit, Küçücük Seden, Cabioglu Neslihan. Promising Oncological and Clinical Outcome in Breast Cancer Patients Undergoing Nipple- or Skin-Sparing Mastectomy With Immediate Reconstruction. 16th Annual Meeting of American Society of Breast Surgeons, April 29-May 3, 2015, Orlando, USA.

    Quelle: Profilseite auf florence.com.tr

  46. 77. Enver ÖZKURT, Mustafa TÜKENMEZ, Burcu Celet ÖZDEN, Gizem ÖNER, Erdem GÜVEN, Mahmut MÜSLÜMANOĞLU, Abdullah İĞCİ, Vahit OZMEN, Ahmet DİNÇÇAĞ, Merdan FAYDA, Seden KÜÇÜCÜK, Neslihan CABİOĞLU. Radiotherapy does not increase implant/expander loss in breast cancer patients who underwent immediate breast reconstruction. 16th Annual Meeting of American Society of Breast Surgeons, April 29-May 3, 2015, Orlando, USA.

    Quelle: Profilseite auf florence.com.tr

  47. 78. Ozmen T, Yuce S, Guler T, Canan Ulun, Ozaydin N, Pruthi S, Akkapulu N, Karabulut K, Ozmen V. The screening of breast cancer awareness and health behaviors of women age 40 to 69 in Mus, the least developed city in Turkey: A population based, cross-sectional study. 2015 ASCO Annual Meeting, J Clin Oncol 33, 2015 (suppl; abstr e12569).

    Quelle: Profilseite auf florence.com.tr

  48. 79. Tukenmez M, Burak Kulle CB, Velidedeoglu M, Agcaoglu O, Parlakgul G, Aydogan F, Onder S, Bozdogan A, Ozkurt E, Muslumanoglu M, Igci A, Dinccag A, Ozmen V, Varol Celik V, Karanlik H, Fayda EM, Sen F, Aydiner A, Cabioglu N. Clinical distuingishing characteristics and management of phyllodes tumors of the breast. 2015 ASCO Annual Meeting, J Clin Oncol 33, 2015 (suppl; abstr e12060).

    Quelle: Profilseite auf florence.com.tr

  49. 80.Ozmen V, Atasoy A, Gokmen E, Ozdogan M, Guler EN, Uras C, Ok E, Demircan O, Isikdogan A, Pilanci KN, Ordu C, Duman O, Ates O, Sen F, Kara H, Oz B, Saip P. Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis. 2015 ASCO Annual Meeting J Clin Oncol 33, 2015 (suppl; abstr e11515).

    Quelle: Profilseite auf florence.com.tr

  50. 81.Ozmen V, Cabioglu N, Gürdal SO, Ozaydın N, Kayhan A, Aribal E. Bahcesehir Mammography Screening Project (BMSP) is cost effective in a developing country. San Antonio Breast Cancer Symposium December 07-12, 2015, San Antonio, Tx, USA.

    Quelle: Profilseite auf florence.com.tr